Clinical trial
Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence
NCT00447564 · Titan Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00447564 |
|---|---|
| Title | Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of Probuphine in Patients With Opioid Dependence |
| Lead sponsor | Titan Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Opioid Dependence |
| Intervention type | Drug |
| Interventions | Probuphine, placebo |
| Enrollment | 163 |
| Start date | Oct 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Mar 14, 2007 |
| Last update posted | Dec 31, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: